Aasia Kalsoom | Development of New Vaccines | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Aasia Kalsoom – Pakistan Council of Scientific and Industrial Research – Pakistan

Aasia Kalsoom
Affiliation Pakistan Council of Scientific and Industrial Research
Country Pakistan
Scopus ID 57204200924
Documents 8
Citations 56
h-index 4
Subject Area Development of New Vaccines
Event International Research Awards on Infectious Diseases

The Innovative Research Award is a research recognition category associated with the International Research Awards on Infectious Diseases. This article presents the supplied bibliographic profile of Aasia Kalsoom, affiliated with the Pakistan Council of Scientific and Industrial Research in Pakistan, with a stated subject area of development of new vaccines. The profile includes publication and citation indicators attributed to the researcher’s supplied Scopus author record. These metrics provide a quantitative overview of indexed scholarly output but do not, on their own, establish the novelty, quality, or clinical impact of individual research contributions. [1]

Abstract

This article outlines the available research-profile information for Aasia Kalsoom, whose stated institutional affiliation is the Pakistan Council of Scientific and Industrial Research. The supplied Scopus profile identifies eight documents, 56 citations, and an h-index of 4. The stated subject area is the development of new vaccines, a field relevant to infectious disease prevention, immunology, antigen research, and vaccine development. The article discusses the significance and limitations of these indicators in the context of research recognition. Specific publications, experimental findings, author contributions, and independently verified award decisions have not been supplied and are therefore not asserted here. [1] [2]

Keywords

Aasia Kalsoom; Innovative Research Award; Pakistan Council of Scientific and Industrial Research; Pakistan; development of new vaccines; infectious diseases; vaccine research; scientific publications; citation analysis; research impact; Scopus author profile; biomedical research.

Introduction

Vaccine development is an important component of infectious disease research. It involves the identification of protective antigens, evaluation of immune responses, assessment of safety, and investigation of strategies that can prevent or reduce the burden of infectious diseases. Research in this area can involve microbiology, immunology, molecular biology, biotechnology, clinical investigation, and public health. The translation of laboratory findings into effective vaccines requires evidence from appropriate experimental and clinical studies. [2] [3]

Research Profile

Aasia Kalsoom is associated in the supplied information with the Pakistan Council of Scientific and Industrial Research in Pakistan. The stated subject area is development of new vaccines. The Scopus author identifier provided for this profile is 57204200924. The profile can be consulted through the publisher’s author-detail page to examine indexed records and associated bibliographic information. [1]

Research Contributions

The supplied subject area places the research profile within the broad field of new vaccine development. Vaccine research can address scientific questions about pathogen biology, antigen selection, immune recognition, immunogenicity, protective efficacy, safety, and implementation. The specific contribution of an individual researcher must, however, be established from publications, project records, documented author roles, and relevant experimental or clinical evidence. [2] [3]

Publications

The supplied bibliometric information lists eight documents associated with the Scopus author identifier 57204200924. A publication-by-publication inventory has not been provided for this article. The linked Scopus author page is the appropriate starting point for verifying document titles, author lists, source titles, publication dates, citation records, and available digital object identifiers. [1]

Research Impact

The supplied profile reports 56 citations across eight documents and an h-index of 4. These indicators describe aspects of the recorded scholarly attention associated with the profile. Citation counts can help identify research outputs that have been referenced by later publications, while the h-index combines publication productivity and citation frequency into a single measure. Neither measure directly evaluates methodological quality, originality, clinical usefulness, or the accuracy of research findings. [1] [3]

Award Suitability

The Innovative Research Award is associated here with the International Research Awards on Infectious Diseases. The supplied institutional affiliation, stated vaccine-development subject area, and bibliometric profile provide contextual information that may be relevant when considering research in the infectious diseases field. The available data alone do not establish eligibility, nomination status, selection, or receipt of the award.[1]

Conclusion

Aasia Kalsoom’s supplied research profile identifies an affiliation with the Pakistan Council of Scientific and Industrial Research in Pakistan and a subject area of development of new vaccines. The provided Scopus indicators comprise eight documents, 56 citations, and an h-index of 4. These figures offer a limited quantitative description of indexed research activity. A fuller scholarly assessment would require verification of the author record, examination of individual publications, and evidence of specific contributions to vaccine or infectious diseases research. Award eligibility and recognition should be established through the official program and its documented evaluation process.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Aasia Kalsoom, Author ID 57204200924. Scopus. Author-profile metrics and document records should be checked against the current database entry.
    https://www.scopus.com/authid/detail.uri?authorId=57204200924
  2. Rasool, M., Malik, A., Waquar, S., Tul-Ain, Q., Jafar, T. H., Rasool, R., & Kalsoom, A. (n.d.). In-silico characterization and in-vivo validation of Albiziasaponin-A, iso-orientin, and salvadorin using a rat model of Alzheimer’s disease.
    https://pubmed.ncbi.nlm.nih.gov/30123124/
  3. Kalsoom, A., Abidi, S. H., Marwat, S. A., Shabbir, G., Naveed, M., & Mughal, A. M. A. (n.d.). Immunopharmacological and structural design of a polyprotein-based multi-epitope vaccine against Powassan virus.
    https://link.springer.com/article/10.1007/s00210-026-05519-y

Salvatore De Simone | Vaccines-Pertussis toxin | Excellence in Research

Posted on by International Research Awards on Infectious Diseases

Excellence in Research

Salvatore De Simone
Oswaldo Cruz Foundation

Salvatore De Simone
Affiliation Oswaldo Cruz Foundation
Country Brazil
Scopus ID 7003443244
Documents 97
Citations 1673
h-index 23
Subject Area Vaccines-Pertussis toxin
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-2172-656X

Salvatore De Simone is a researcher affiliated with the Oswaldo Cruz Foundation in Brazil whose scientific activities have contributed to studies involving infectious diseases, immunology, vaccine-related investigations, and molecular approaches relevant to public health. His publication record, citation performance, and sustained scholarly output reflect continued engagement with internationally relevant biomedical research topics. The recognition of research excellence within the field of Vaccines-Pertussis toxin highlights the importance of advancing scientific understanding of vaccine development, pathogen-host interactions, and translational applications in disease prevention.[1]

Abstract

This article presents an academic overview of Salvatore De Simone and his research activities associated with infectious diseases and vaccine-related investigations. His scientific contributions support the advancement of biomedical knowledge through multidisciplinary approaches involving molecular biology, immunology, pathogen characterization, and translational research. Particular attention is given to scientific themes connected with Vaccines-Pertussis toxin, where understanding immune responses and vaccine effectiveness remains essential for disease prevention strategies. The researcher’s publication profile, citation performance, and documented scholarly impact illustrate sustained engagement with internationally recognized research efforts and collaborative scientific advancement.[1]

Keywords

Vaccines, Pertussis Toxin, Infectious Diseases, Immunology, Public Health, Biomedical Research, Molecular Biology, Translational Medicine, Vaccine Development, Scientific Impact.

Introduction

The study of infectious diseases continues to represent a major area of scientific inquiry due to the ongoing emergence of pathogens and the need for effective preventive interventions. Research focused on vaccines and associated biological mechanisms plays an essential role in improving population health outcomes. Investigations involving pertussis toxin and vaccine-associated immune responses contribute to understanding pathogen virulence, immunogenicity, and long-term protection.[2]

Research Profile

Salvatore De Simone has developed a research profile characterized by interdisciplinary scientific investigations addressing biological systems relevant to infectious diseases. Bibliometric indicators including publication volume, citation count, and h-index demonstrate measurable scholarly engagement and continuing influence across multiple research communities.[1]

Research Contributions

Research contributions associated with Salvatore De Simone encompass investigations relevant to infectious disease biology, molecular mechanisms, immunological responses, and vaccine-related scientific questions. Contributions within vaccine science and studies connected to pertussis toxin provide valuable perspectives regarding antigenic properties, immune modulation, and mechanisms that influence vaccine efficacy and safety.[2]

Publications

The researcher’s publication portfolio includes peer-reviewed scientific articles contributing to knowledge within infectious disease research and related biomedical disciplines. The documented publication output indicates sustained scientific productivity and participation in scholarly communication through internationally indexed journals. Citation metrics suggest that published findings have informed subsequent investigations and supported broader scientific discourse.[1]

Research Impact

Research impact may be evaluated through publication influence, citation performance, scientific visibility, and contribution to advancing disciplinary knowledge. With 1,673 citations and an h-index of 23, the available bibliometric indicators suggest a sustained level of recognition within the scientific community.[1]

Award Suitability

The International Research Awards on Infectious Diseases recognizes individuals whose scholarly activities contribute to advancing scientific understanding and innovation. Salvatore De Simone’s documented publication record, citation metrics, institutional affiliation, and engagement with vaccine-related research themes align with the objectives commonly associated with academic recognition programs.[3]

Conclusion

Salvatore De Simone represents a research profile characterized by scientific productivity, interdisciplinary collaboration, and measurable scholarly influence. His work contributes to ongoing investigations in infectious diseases and vaccine-related science, including areas associated with pertussis toxin research. Through publications, citations, and continued engagement with biomedical inquiry, his contributions support the advancement of knowledge relevant to public health and scientific innovation.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Salvatore De Simone, Author ID 7003443244. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003443244
  2. ORCID. (n.d.). ORCID profile of Salvatore De Simone. ORCID Registry.
    https://orcid.org/0000-0002-2172-656X
  3. Rangel, K., Chagas, T. P. G., & De-Simone, S. G. (n.d.). Acinetobacter baumannii infections in times of COVID-19 pandemic.
    https://www.mdpi.com/2076-0817/12/1/41
  4. De-Simone, S. G., Lechuga, G. C., Napoleão-Pêgo, P., Freitas, M. S., & Cardozo, S. V. (n.d.). Screening epitopes through comparative analysis of children and mice immune responses to pertussis toxin subunits (S1–S5) induced by whole-cell pertussis vaccination.
    https://www.mdpi.com/2076-393X/14/5/413

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Posted on by International Research Awards on Infectious Diseases

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Wenzhou Sixth People’s Hospital | China.

Author Profile

Scopus

🎓Education

Master’s Degree – Wenzhou Medical College

đź’ĽProfessional Experience

Mr. Jiang has held several key leadership positions in the healthcare sector. He serves as the Deputy Secretary of the Party Committee at Wenzhou Central Hospital and previously led as the President of the Sixth People’s Hospital of Wenzhou. During the COVID-19 pandemic, he played a critical role as the Leader of the COVID-19 Treatment Team in Wenzhou, ensuring effective patient care and outbreak control. Additionally, he led the Wenzhou Medical Team in Shanghai, where he also served as the Temporary Party Branch Secretary, overseeing medical operations and emergency response efforts.

đź“šAcademic Contributions

Mr. Jiang has made significant contributions to medical research, with 17+ SCI-indexed publications and over 30 articles in Chinese medical journals. He has also served as an editor of two medical books, further advancing knowledge in infectious disease management. His research efforts extend to national and provincial projects, where he has played a key role in developing innovative healthcare solutions and public health strategies.

🧑‍🔬Technical Skills 

Mr. Xiangao Jiang possesses advanced expertise in infectious disease diagnosis and treatment, specializing in managing hepatitis, chronic liver diseases, tuberculosis, and other critical infections. His proficiency extends to critical care management, where he has played a key role in handling complex and severe infectious disease cases. Additionally, his strong leadership in medical administration and public health response has been demonstrated through his roles in hospital management, pandemic control, and policy implementation, ensuring effective healthcare delivery and crisis management.

đź“šTeaching Experience

Tutor for postgraduate students at Wenzhou Medical University & Shanghai University

🏆Awards and Honors

Mr. Jiang’s outstanding contributions to medicine and healthcare have earned him the prestigious titles of Wenzhou Famous Doctor and Ou Yue Famous Doctor. His leadership and expertise have also been recognized through his selection as a Health Leading Talent under Zhejiang Province’s “Ten Thousand People Plan”, a distinction awarded to top professionals making significant impacts in their fields.

🔬Research Interests

Mr. Jiang’s research focuses on hepatitis and chronic liver diseases, with an emphasis on understanding disease progression and developing effective treatment strategies. He is also deeply engaged in infectious disease epidemiology, studying patterns and risk factors to enhance prevention and control measures. Additionally, his work in public health and outbreak management has contributed to improving emergency response strategies and healthcare policies, particularly in the face of emerging infectious threats.

📑Notable Publications 

‘Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China’
Authors: C. Qiu, Chaochao; X. Lin, Xiaoqing; Q. Zhang, Qiang; J. Shi, Jichan; X. Jiang, Xiangao
Year: 2025
Journal: BMC Infectious Diseases

‘Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus’
Authors: L. Wu, Lianpeng; N. Chen, Na; D. Xia, Dandan; X. Jiang, Xiangao
Year: 2025
Journal: Frontiers in Medicine

 ‘Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysisy’
Authors: X. Cai, Xiaoxiao; X. Xu, Xueqin; G. He, Guiqing; X. Jiang, Xiangao; L. Wu, Lianpeng
Year: 2024
Journal: BMC Infectious Diseases

‘Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China‘

Authors: G. He, Guiqing; Q. Zheng, Qingyong; J. Wu, Jing; X. Jiang, Xiangao; X. Yu, Xia
Year: 2024
Journal: Microbiology Spectrum